REGISTERED NUMBER: |
Morio-Labs Limited |
Unaudited Financial Statements |
for the period |
24 February 2022 to 28 February 2023 |
REGISTERED NUMBER: |
Morio-Labs Limited |
Unaudited Financial Statements |
for the period |
24 February 2022 to 28 February 2023 |
Morio-Labs Limited (Registered number: 13938556) |
Contents of the Financial Statements |
for the period 24 February 2022 to 28 February 2023 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 3 |
Morio-Labs Limited |
Company Information |
for the period 24 February 2022 to 28 February 2023 |
Director: |
Registered office: |
Registered number: |
Accountants: |
Chartered Accountants |
New Derwent House |
69-73 Theobalds Road |
London |
WC1X 8TA |
Morio-Labs Limited (Registered number: 13938556) |
Balance Sheet |
28 February 2023 |
Notes | £ | £ |
Fixed assets |
Tangible assets | 4 |
Current assets |
Stocks |
Debtors | 5 |
Cash at bank |
Creditors |
Amounts falling due within one year | 6 |
Net current liabilities | ( |
) |
Total assets less current liabilities | ( |
) |
Capital and reserves |
Called up share capital | 7 |
Retained earnings | 8 | ( |
) |
Shareholders' funds | ( |
) |
The director acknowledges her responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements were approved by the director and authorised for issue on |
Morio-Labs Limited (Registered number: 13938556) |
Notes to the Financial Statements |
for the period 24 February 2022 to 28 February 2023 |
1. | Statutory information |
Morio-Labs Limited is a |
2. | Accounting policies |
Basis of preparing the financial statements |
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
Tangible fixed assets |
Fixtures and fittings | - |
Stocks |
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
Going concern |
The company meets its day to day working capital requirements through the support of the directors and shareholders of the company. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis. |
3. | Employees and directors |
The average number of employees during the period was |
4. | Tangible fixed assets |
Fixtures |
and |
fittings |
£ |
Cost |
Additions |
At 28 February 2023 |
Depreciation |
Charge for period |
At 28 February 2023 |
Net book value |
At 28 February 2023 |
5. | Debtors: amounts falling due within one year |
£ |
Trade debtors |
Other debtors |
Morio-Labs Limited (Registered number: 13938556) |
Notes to the Financial Statements - continued |
for the period 24 February 2022 to 28 February 2023 |
6. | Creditors: amounts falling due within one year |
£ |
Trade creditors |
Amounts owed to group undertakings |
Taxation and social security |
Other creditors |
7. | Called up share capital |
Allotted, issued and fully paid: |
Number: | Class: | Nominal |
value: | £ |
Ordinary | £1 | 100 |
100 Ordinary shares of £1 each were allotted and fully paid for |
8. | Reserves |
Retained |
earnings |
£ |
Deficit for the period | ( |
) |
At 28 February 2023 | ( |
) |